For more advanced and metastatic PCa, the gold standard strategy is androgen deprivation therapy (ADT) [4], which is initially highly effective at reducing tumor size, lowering prostate-specific antigen (PSA) levels and extending survival time [5]. This evidence concerns the gene KLK3 and neoplasm.